Differential clinical outcome according to KRAS, NRAS and BRAF genotype detected by massive parallel sequencing of metastatic colorectal cancer patients treated with first line FIr-B/FOx adding bevacizumab to triplet chemotherapy / Bruera, G.; Pepe, F.; Malapelle, U.; Pisapia, P.; Dal Mas, A.; Calvisi, G.; Troncone, G.; Ricevuto, E.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 28:(2017), pp. iii95-iii96. [10.1093/annonc/mdx261.271]
Differential clinical outcome according to KRAS, NRAS and BRAF genotype detected by massive parallel sequencing of metastatic colorectal cancer patients treated with first line FIr-B/FOx adding bevacizumab to triplet chemotherapy
Pepe, F.;Malapelle, U.;Pisapia, P.;Troncone, G.;
2017
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
